Abstract
The strategies vary by which viruses invade a host and cause disease.(1) In return, the host defense systems that are called upon to intercept and sequester those pathogenic agents also differ.(2) The natural defense system of the infected animal constitutes the first barrier of active defense. These mechanisms act relatively nonspecifically and require no prior exposure to the invading microorganism in order to be active. Macrophages, interferon, and natural killer (NK) cells are three natural defense systems that are thought to be important in the control of herpes simplex virus (HSV) infections and will be the focus of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Notkins, A. L., 1974, Commentary: Immune mechanisms by which the spread of viral infection is stopped, Cell Immunol. 11:478–83.
Allison, A. C., 1974, Interactions of antibodies, complement components and various cell types in immunity against virus and pyogenic bacteria, Transplant. Rev. 19:3– 55.
Nahmias, A. J. and Roizman, B., 1973, Infection with herpes-simplex viruses 1 and 2, N. Engl. J. Med. 299:667–674, 719–725, 781– 789.
Roizman, B., 1974, Herpesviruses, latency and cancer, J. Reticuloendothel. Soc. 15:312– 321.
Corey, L., 1982, The natural history of genital herpes simplex virus. Perspectives on an increasing problem, in: The Herpesviruses (B. Roizman, C. Lopez, eds.), Plenum Press, New York, pp. 1–35.
Dowdle, W. R., Nahmias, A. J., Harwell, R. W., and Pauls, F. P., 1967, Association of antigenic type of herpesvirus hominis with site of viral recovery, J. Immunol. 99:974– 980.
Stevens, J. G., 1975, Latent herpes simplex virus and the nervous system, Curr. Top. Micro. Immunol. 70:31– 50.
Hill, T. J., Field, H. J., and Blyth, W. A., 1975, Acute and recurrent infection with herpes simplex virus in the mouse: A model for studying latency and recurrent disease, J. Gen. Virol. 28:341– 353.
Rouse, B. T., 1984, Cell-mediated immune mechanisms, in: Immunobiology of Herpes Simplex Virus Infection (B. T. Rouse, C. Lopez eds.), CRC Press, Boca Raton, FL, pp. 107–120.
Abghari, S. Z., Stulting, R. D., Nigida, S. M., Downer, D. N., Kindle, J. C., and Nahmias, A. J., 1986, Spread of HSV and establishment of latency after corneal infection in inbred mice, J. Invest. Ophthalmol. 27:77– 82.
Bang, F. B., 1978, Genetics of resistance of animals to viruses: Introduction and studies in mice, Adv. Virus Res. 23:269– 347.
Lopez, C., 1975, Genetics of natural resistance to herpesvirus infections in mice, Nature 258:152–153.
Kirchner, H., Kochen, M., Hirt, H. M., and Munk, K., 1978, Immunological studies of HSV infection of resistant and susceptible inbred strains of mice, Z. Immun. Forsch. 154:147– 154.
Kirchner, H., Hirt, H. M., Rosenstreich, D. L., and Mergenhagen, S. E., 1978, Resistance of C3H/HeJ mice to lethal challenge with herpes simplex virus, Proc. Soc. Exp. Biol. Med. 157:29– 32.
Zawatzky, R., Hilfenhaus, J., Marucci, F., and Kirchner, H., 1981, Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunology and of interferon induction, J. Gen. Virol. 43:31– 38.
Caspary, L., Schindling, B., Dundarov, S., and Falke, D., 1980, Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2, Arch. Virol. 65:219– 227.
Shellam, G. R., and Flexman, J. P., 1986, Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice, J. Virol. 58:152– 156.
Lopez, C., 1980, Resistance to HSV-1 in the mouse is governed by two major, independently segregating non-H-2 loci, Immunogenics 11:87–92.
Mogensen, S. C., 1979, Role of macrophages in natural resistance to virus infections, Microbiol Rev. 43:1–26.
Lopez, C, 1978, Immunological nature of genetic resistance of mice to herpes simplex virus type 1 infection, in: Oncogenesis and Herpesviruses III (G. de The, W. Henle, F. Rapp, eds.), IARC, Lyon, France, pp. 775–778.
Rajcani, J., Gajdosova, E., and Mayer, V., 1974, Pathogenesis of herpesvirus hominis infection in immunosuppressed mice, Acta Virol. 18:135–142.
Rager-Zisman, B., and Allison, A. C., 1976, Mechanisms of immunologic resistance to herpes simplex virus 1 (HSV-1) infection, J. Immunol. 116:35– 40.
Hough, V., and Robinson, T. W. E., 1975, Exacerbation and reactivation of herpesvirus hominis infection in mice by cyclophosphamide, Arch. Virol. 48:75– 83.
Armerding, D., Scriba, M., Hren, A., and Rossiter, H., 1982, Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection, Antivir. Res. 2:3– 11.
Armerding, D., and Rossiter, H., 1981, Induction of natural killer cells by herpes simplex virus type 2 in resistant and sensitive inbred mouse strains, Immunobiology 158:369–379.
Schneweis, K. E., and Saftig, V., 1981, The vaginal herpes simplex virus infection of resistant (C57B1) mice, Int. Herpesvirus Workshop, p. 144.
Lopez, C., 1981, Resistance to herpes simplex virus-type 1 (HSV-1), in: Natural Resistance to Tumors and Viruses (O. Haller, ed), Springer-Verlag, New York, pp. 15–24.
Price, R. W., and Schmitz, J., 1978, Reactivation of latent herpes simplex virus infection of the autonomic nervous system by post-ganglionic neurectomy, Infect. Immun. 19:523– 532.
Cudkowicz, G., 1975, Genetic control of resistance to allogeneic and zenogeneic bone marrow grafts in mice, Transplant Proc. 7:155–159.
Cudkowicz, G., and Bennett, M., 1971, Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice, J. Exp. Med. 134:83– 102.
Bennett, M., 1973, Prevention of marrow allograft rejection with radioactive strontium: Evidence for marrow-dependent effector cells, J. Immunol. 110:510– 516.
Bennett, M., Baker, E. E., Eascott, J. W., Kumar, V., and Yonkosky, D., 1976, Selective elimination of marrow precursors with the bone-seeking isotope 89Sr: Implications for hemopoesis, lymphopoesis, viral leukemogenesis and infection, J. Reticuloendothel. Soc. 20:71– 87.
Lopez, C., Ryshke, R., Bennett, M., 1980, Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infections in mice, Infect. Immun. 28:1028– 1032.
Zawatzky, R., Hilfenhaus, J., and Kirchner, H., 1979, Resistance of nude mice to herpes simplex virus and correlation with in vitroproduction of interferon, Cell. Immunol. 47:424– 428.
Mori, R., Takeya, K., Minamishima, Y., and Tasiki, T., 1965, Effect of thymectomy on experimental viral infections of mice. I. Herpes simplex virus and Coksaki B5 virus, Proc.Jpn. Acad. 41:975– 982.
Chmielarczyk, W., Engler, H., Ernst, R., Optiz, U., and Kirchner, H., 1985, Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus, J. Gen. Virol. 66:1087– 1094.
Schlabach, A. J., Martinez, D., Field, A. K., and Tytell, A. A., 1979, Resistance of C57 mice to primary systemic herpes simplex virus infection: Macrophage dependence and T-cell independence, Infect. Immun. 26:615– 620.
Kastrukoff, L. F., Lau, A. S., and Puterman, M. L., 1986, Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice, J. Gen. Virol. 67:613– 621.
Abghari, S. Z., Stulting, R. D., Nigida, S. M., Downer, D. N., Kindle, J. C., and Nahmias, A. J., 0000, Spread of HSV and establishment of latency after corneal infection in inbred mice, Invest. Ophthalmol. 27:77–82.
Harnett, G. B., and Schellam, G. R., 1982, Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: Correlation with in vivoresistance, J. Gen. Virol. 62:39– 47.
Collier, L. H., Scott, Q. J., and Pani, A., 1983, Variation in resistance of cells from inbred strains of mice to herpes simplex virus type 1, J. Gen. Virol. 64:1483– 1490.
Abghari, S. Z., Stulting, R. D., Nigida, S. M., Downer, D. N., Kindle, J. C., and Nahmias, A. J., 1986, Replication of herpes simplex virus in fibroblast cells from inbred mice, J. Invest. Ophthalmol. 27:57– 82.
Mogensen, S. C., 1976, Biological conditions influencing the focal necrotic hepatitis test for differentiation between herpes simplex virus type 1 and 2, Acta Pathol. Microbiol. Scand. (B) 84:154– 158.
Mogensen, S. C., Teisner, B., and Andersen, H. K., 1974, Focal necrotic hepatitis in mice as a biological marker for differentiation of herpesvirus hominis type 1 and 2, J. Gen. Virol. 25:151– 155.
Hirsch, J. G., and Fedorko, M. E., 1970, Morphology of mouse mononuclear phagocytes, in: Mononuclear Phagocytes( R. von Furth, ed.), Blackwell, Oxford, U.K., p. 7.
Andervout, H. B., 1927, Activity of herpetic viruses in mice, Am. J. Hyg. 14:383– 393.
Johnson, R. T., 1964, The pathogenesis of herpesvirus encephalitis. I. Virus pathways to the nervous system of suckling mice demonstrated by fluorescent antibody staining, J. Exp. Med. 119:343– 358.
Johnson, R. T., 1964, The pathogenesis of herpesvirus encephalitis. II. A cellular basis for the development of resistance with age, J. Exp. Med. 120:359– 373.
Hirsch, M. S., Zisman, B., and Allison, A. C., 1970, Macrophages and age-dependent resistance to herpes simplex virus in mice, J. Immunol. 104:1160– 1165.
. Halpern, B., Frey, A., Crepin, O., Platica, O., Lorinet, A. M., Rabourdin, A., Sparros, L., and Isac, R., 1973, Corynebacterium parvum, a potent immunostimulant in experimental infections and in malignancies, in: Immunopotentiation, Vol. 18, Ciba Foundation Symposium, Associated Scientific Publishers, New York p. 217.
Lopez, C., and Dudas, G., 1979, Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice, Infect. Immun. 23:432– 437.
Armerding, D., Mayer, P., Scriba, M., Hren, A., and Rossiter, H., 1981, In vivo modulation of macrophage functions by herpes simplex virus type 2 in resistant and sensitive inbred mouse strains, Immunobiology 160:217–227.
Brucher, J., Domke, I., Schroder, C. H., and Kirchner, H., 1984, Experimental infection of inbred mice with herpes simplex virus. VI. Effect of interferon on in vitrovirus replication in macrophages, Arch. Virol. 82:83– 93.
Mogensen, S., 1977, Role of macrophages in hepatitis induced by herpes simplex virus types 1 and 2, Infect. Immun. 15:686– 691.
Mogensen, S. C., 1978, Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 in mice, Infect. Immun. 19:46– 59.
Kiessling, R., Hochman, P. S., Haller, O., Shearer, G. M., Wigzell, H., and Cutkowicz, G., 1977, Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts, Eur. J. Immunol. 7:663– 669.
Haller, O., Kiessling, R., Orn, A., and Wigzell, H., 1977, Generation of natural killer cells: An autonomous function of the bone marrow, J. Exp. Med. 145:1411– 1416.
Morahan, P. S., Coleman, P. H., Morse, S. S., and Volkman, A., 1983, Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: Effects of immunomodulaters in beige mice and 89Sr-treated mice, Infect. Immun. 37:1079– 1085.
Habu, S., Akamatsu, K., Tamaoki, N., and Okumura, K., 1984, In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice, J. Immunol. 133:2743–2747.
Bukowski, J. F., and Welsh, R. M., 1986, The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1, J. Immunol. 136:3481– 3485.
Rager-Zisman, B., Quan, P.-C., Rosner, M., Moller, J. R., and Bloom, B. R., 1987, Role of NK cells in protection of mice against herpes simplex virus-1 infection, J. Immunol. 138:884– 888.
Isaacs, A., and Lindenmann, J., 1957, Virus interference. I. The interferons, Proc. R. Soc. 147:258– 267.
Gresser, I., 1977, Commentary: On the varied biologic effects of interferon, Cell. Immunol. 34:406– 415.
Stewart, W. E., 1979, The Interferon System, Springer, Vienna.
Gidlund, M., Anders, O., Wigzell, H., Senik, A., and Gresser, I., 1979, Enhanced NK cell activity in mice injected with interferon and interferon inducers, Nature 273:759–761.
Huang, K. Y., Donahoe, R. M., Gordon, F. B., and Dressier, H. R., 1971, Enhancement of phagocytosis by interferon-containing preparation, Infect. Immun. 4:581– 588.
Gresser, I., Tovey, M. G., Maury, C., and Bandu, M.-T., 1976, Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex virus, Maloney’s sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses, J. Exp. Med. 144:1316– 1323.
Wrzos, H., Murasko, D. M., and Rapp, F., 1986, Effect of antibody to interferon on genital herpesvirus infection in mice, Micro. Pathol. 1:71– 78.
Zawatzky, R., Hilfenhaus, J., and Kirchner, H., 1979, Resistance of nude mice to herpes simplex virus and correlation with in vitroproduction of interferon, Cell. Immunol. 47:424– 428.
Zawatzky, R., Hilfenhaus, J., Marcucci, F., and Kirchner, H., 1981, Experimental in fection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction, J. Gen. Virol. 53:31– 38.
Engler, H., Zawatzky, R., Goldbach, A., Schroder, C. H., Weyand, C., Hammerling, G. J., and Kirchner, H., 1981, Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in peritoneal exudate, J. Gen. Virol. 55:25– 30.
Engler, H., Zawatzky, R., Kirchner, H., and Armerding, D., 1982, Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice, Arch. Virol. 74:239– 247.
Zawatzky, R., Gresser, I., DeMaeyer, E., and Kirchner, H., 1982, The role of interferon in resistance of C57BL/6 mice to various doses of herpes simplex virus type 1, J. Infect. Dis. 146:405– 410.
Zawatzky, R., Kirchner, H., DeMaeyer-Guignard, Q., and DeMaeyer, E., 1982, X-linked locus influences the amount of circulating interferon induced in the mouse by herpes simplex virus type 1, Virology 63:325–332.
Kirchner, H., Engler, H., Schroder, C. H., Zawatzky, R., and Storch, E., 1983, Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice, J. Gen. Virol. 64:437– 441.
Chmielarczyk, W., Engler, H., Brucher, J., and Kirchner, H., 1983, Herpes simplex virus-induced interferon production and activation of natural killer cells in SM/J mice, relation to antiviral resistance, Antiviral Res. 3:325–333.
Chmielarczyk, W., Domke, I., and Kirchner, H., 1985, Role of interferon in the resistance of C3H/HeJ mice to infection with herpes simplex virus, Antiviral Res. 5:55–59.
Pederson, E. B., Haahr, S., and Mogensen, 1983, X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production, Infect. Immun. 42:740– 746.
Daniels, C. A., Kleinerman, E. S., and Snyderman, R., 1978, Abortive and productive infections of human mononuclear phagocytes by type 1 herpes simplex virus, Am. J. Pathol. 91:119– 136.
Trofatter, K. F. Jr., Daniels, C. A., Williams, R.J. Jr., and Gall, S. A., 1979, Growth of type-2 herpes simplex virus in newborn and adult mononuclear leukocytes, Intervirology 11:117–123.
Linnavuori, K., and Hovi, T., 1981, Herpes simplex virus infection in human monocyte cultures: Dose-dependent inhibition of monocyte differentiation resulting in abortive infection, J. Gen. Virol. 52:381– 385.
Grogan, E., Miller, G., Moore, T., Robinson, J., and Wright, J., 1981, Resistance of neonatal human lymphoid cells to interferon by herpes simplex virus overcome by aging cells in culture, J. Infect. Dis. 144:547– 556.
Diamond, R. D., Keller, R., Lee, G., and Finkel, D., 1977, Lysis of cytomegalovirus- infected human fibroblasts and transformed human cells by peripheral blood lymphoid cells from normal human donors, Proc. Soc. Exp. Biol. Med. 154:259– 263.
Santoli, D., Trinchieri, G., and Lief, F. S., 1978, Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte, J. Immunol. 121:526– 531.
Ching, C., and Lopez, C., 1979, Natural killing of herpes simplex virus type-1 infected target cells: Normal human responses and influence of anti-viral antibody, Infect. Immun. 26:49– 56.
Timonen, T., and Saksela, E., 1980, Isolation of human NK cells by density gradient centrifugation, J. Immunol. Methods 36:285– 291.
Timonen, T., Ortaldo, R. R., and Herberman, R. B., 1981, Characteristics of human granular lymphocytes and relationship to natural killer cells, Fed. Proc. 40:2705– 2710.
Fitzgerald, P. A., Evans, R., Kirkpatrick, D., and Lopez, C., 1983, Heterogeneity of human NK cells: Comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets, J. Immunol. 130:1663– 1668.
Lopez, C., Kirkpatrick, D., Sorell, M., O’Reilly, R. J., and Ching, C., 1979, Association between pretransplant natural kill and graft versus host disease following stem cell transplantation, Lancet 2:1103–1106.
Sorell, M., Kapoor, N., Kirkpatrick, D., Rosen, J. F., Chaganti, R. S., Lopez, C., Dupont, B., Pollack, M., Terrin, B. N., Harris, M. B., Vine, D., Rose, J. S., Goosen, C., Lane, J., Good, R. A., and O’Reilly, R. J., 1981, Marrow transplantation for juvenile osteopetosis, Am. J. Med. 70:1280– 1287.
Kumar, V., Ben-Ezra, J., Bennett, M., and Sonnenfeld, G., 1979, Natural killer cells in mice treated with 89Sr: Normal target-binding cell numbers but inability to kill even after interferon administration, J. Immunol. 123:1832– 1838.
Lust, J. A., Kumar, V., Burton, R. C., Barlett, S. P., and Bennett, M., 1981, Heterogeneity of natural killer cells in the mouse, J. Exp. Med. 154:306– 317.
Ault, K. A., and Springer, T. A., 1981, Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells, J. Immunol. 126:359– 364.
Stutman, O., Paige, C. J., and Figarella, E., 1978, Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility, J. Immunol. 121:1819– 1826.
Stutman, O., Lattime, E. C., and Figarella, E. F., 1981, Natural cytotoxic cells against solid tumors in mice: A comparison with natural killer cells, Fed. Proc. 40:2699– 2703.
Messina, C., Kirkpatrick, D., Fitzgerald, P. A., O’Reilly, R. J., Siegal, F. P., Cunningham-Rundles, C., Blaese, M., Oleske, J., Pahwa, S., and Lopez, C., 1986, Natural killer cell function and interferon generation in patients with primary immunodeficiencies, Clin. Immunol. Immunopathol. 39:394– 404.
Feldman, M., Curl, S., and Fitzgerald-Bocarsly, P., 1987, The accessory cell function of HLA-DR positive cells in NK-mediated lysis of HSV-1-infected fibroblasts, Fed. Proc. 46:483.
Bandyopadhyay, S., Perussia, B., Trinchieri, G., Miller, D. S., and Starr, S. T., 1986, Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts, J. Exp. Med. 164:180– 195.
Fitzgerald-Bocarsly, P., Feldman, M., Curl, S., Tehrani, S., and Denny, T., 1987, Co¬operation between CD-16-positive NK cells and DR-positive accessory cells in the lysis of HSV-infected fibroblasts, J. Leuk. Biol. 42:154.
Colmenares, C., and Lopez, C., 1986, Enhanced lysis of herpes simplex virus type-1-infected mouse cell lines by NC and NK effectors, J. Immunol. 136:3473– 3480.
Trinchieri, G., Santoli, D., and Koprowski, H., 1978, Spontaneous cell-mediated cytotoxicity in humans: Role of interferon and immunoglobulins, J. Immunol. 120:1849– 1855.
Trinchieri, G., and Santoli, D., 1978, Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis, J. Exp. Med. 147:1314– 1333.
Fitzgerald, P. A., Von Wussow, P., and Lopez, C., 1982, Role of interferon in natural kill of HSV-1-infected fibroblasts, J. Immunol. 129:819– 825.
Bishop, G. A., Glorioso, J. C., and Schwartz, S. A., 1983, Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity, J. Exp. Med. 157:1544– 1561.
Moller, J. R., Rager-Zisman, B., Quan, P.-C., Schattner, A., Panush, D., Rose, J. K., and Bloom, B. R., 1985, Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus, Proc. Natl. Acad. Sci. USA 82:2456– 2459.
Honess, R., and Watson, D., 1977, Unity and diversity in the herpesviruses, J. Gen. Virol. 37:15– 37.
Bishop, G. A., Manlin, S. D., Schwartz, S. A., and Glorioso, J. C., 1984, Human natural killer cell recognition of herpes simplex virus type-1 glycoproteins: Specificity analysis with the use of monoclonal antibodies and antigenic variants, J. Immunol. 133:2206– 2214.
Bishop, G. A., Kumel, G., Schwartz, S. A., and Glorioso, J. C., 1986, Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type-1 glycoproteins, J. Virol. 57:294– 300.
El Daher, N., and Betts, R. F., 1985, New observations regarding killing of fibroblasts infected with herpes simplex virus: Cooperation between illutable factor and peripheral mononuclear cells, J. Infect. Dis. 152:1197– 1205.
Shore, S. L., Black, C. M., Melewicz, F. M., Wood, P. A., and Nahmias, A. J., 1976, Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus, J. Immunol. 116:194– 201.
Dixon, R., and Schaffer, P. A., 1980, Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP 175, J. Virol. 36:189– 203.
Borysiewicz, L., Rodger, B., Morris, S., Graham, S., and Sissons, J., 1985, Lysis of human cytomegalovirus-infected fibroblasts by natural killer cells: Demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells, J. Immunol. 134:2695– 2701.
Bradley, T., and Bonavida, B., 1981, Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-cellular cytotoxicity can be mediated by the same human effector cell as determined by the 2-target conjugate assay, J. Immunol. 129:2260– 2265.
Peter, H. H., Dallugge, H., Zawatzky, R., Eular, S., Leibold, W., and Kirchner, H., 1980, Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, herpes simplex virus and Corynebacterium parvum, Eur. J. Immunol. 10:547– 555.
Kirchner, H., Peter, H. H., Hirt, H. M., Zawatzky, R., Dalluge, H., and Bradstreet, P., 1979, Studies of the producer cell of interferon on human lymphocyte cultures, Immunobiology 156: 6575.
Djeu, Y., Stocks, N., Zoon, K., Stanton, G. J., Timonen, T., and Herberman, R. B., 1982, Positive self-regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpesviruses, J. Exp. Med. 156:1222– 1234.
Fitzerald-Bocarsley, P. A., Feldman, M., Mendelsohn, M., Curl, S., and Lopez, C., 1988, Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer cells, J. Leuk. Biol. 43:323– 334.
Perussia, B., Fanning, V., and Trinchiere, G., 1985, A leukocyte subset bearing HLA- DA antigens is responsible for in vitro alpha-interferon production in response to viruses, Nat. Immun. Cell Growth Regul. 4:120– 137.
Fitzgerald, P. A., Mendelsohn, M., and Lopez, C., 1985, Human natural killer cells limit replication of herpes simplex virus type-1 in vitro, J. Immunol. 134:2666– 2672.
Leibson, P. J., Hunter-Laszlo, M., and Hayward, A. R., 1986, Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells, J. Virol. 57:976– 982.
Leibson, P. J., Hunter-Laszlo, M., Douvas, G. S., and Hayward, A. R., 1986, Impaired neonatal natural killer-cell activity to herpesvirus: Decreased inhibition of viral replication and altered response to lymphokines, J. Clin. Immunol. 6:216– 224.
Yasukawa, M., and Kobayashi, Y., 1985, Inhibition of herpes simplex virus replication in vitro by human cytotoxic T-cell clones and natural killer cell clones, J. Gen. Virol. 66:2225– 2229.
Lopez, C., Kirkpatrick, D., Read, S., Fitzgerald, P. A., Pitt, J., Pahwa, S., Ching, C. Y., and Smithwick, E. M., 1983, Correlation between low natural kill of HSV-1-infected fibroblasts, NK(HSV-l) and susceptibility to herpesvirus infections, J. Infect. Dis. 147:1030– 1035.
Kohl, S., Frazier, J. J., Greenberg, S. B., Pickering, L. K., and Loo, L.-S., 1981, Interferon induction of natural killer cytotoxicity in human neonates, J. Pediatr. 98:379– 384.
Lipinski, M., Virelizier, J.-L., Tursz, T., and Griscelli, C., 1980, Natural killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production, Eur. J. Immunol. 10:246– 249.
Stiehm, R. E., 1980, The human neonate as an immunocompromised host, in: Infections in the Immunocompromised Host—Pathogenesis, Prevention and Therapy, Volume 11 ( J. Verhoef, P. K. Peterson, P. G. Quie, eds.), Elsevier/North-Holland, New York, p. 77.
Blaese, M., Strober, W., and Waldman, T. A., 1975, Immunodeficiency in the Wiscott- Aldrich Syndrome, in: Immunodeficiency in Man and Animals( D. Bergsman, R. A. Good, and J. Finstad, eds.), Sinauer, Sunderlind, MD., p. 250.
Fauci, A. S., Macher, A. M., Longo, D. L., Lane, H. C., Rook, A. H., Masur, H., and Gelmann, E. P., 1984, Acquired immune deficiency syndrome: Epidemiologic clinical immunologic and therapeutic considerations, Ann. Intern. Med. 100:92– 106.
Siegal, F. P., Lopez, C., Hammer, G. S., Brown, A. E., Kornfeld, S. J., Gold, J., Hassett, J., Hirshman, S. Z., Cunningham-Rundels, C., Adelsberg, B. R., Parham, D. M., Siegal, M., Cunningham-Rundels, S., and Armstrong, D., 1981, Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions, N. Engl. J. Med. 305:1439– 1444.
Lopez, C., Fitzgerald, P. A., and Siegal, F. P., 1983, Severe acquired immune deficiency syndrome in male homosexuals: Diminished capacity to make interferon-alpha in vitroassociated with severe opportunistic infections, J. Infect. Dis. 148:962– 966.
Siegal, F. P., Lopez, C., Fitzgerald, P. A., Shah, K., Baron, P., Leiderman, I. Z., Imperato, D., and Landesman, S., 1986, Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity, J. Clin. Invest. 78:115– 123.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Lopez, C., Fitzgerald-Bocarsly, P. (1989). Natural Host Defense Systems Active against Herpes Simplex Virus Infections. In: Reynolds, C.W., Wiltrout, R.H. (eds) Functions of the Natural Immune System. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0715-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0715-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8046-0
Online ISBN: 978-1-4613-0715-0
eBook Packages: Springer Book Archive